4basebio PLC (LON:4BB – Get Free Report) insider Amy Walker purchased 1,151 shares of the firm’s stock in a transaction dated Friday, February 28th. The stock was bought at an average cost of GBX 1,120 ($14.23) per share, for a total transaction of £12,891.20 ($16,382.26).
4basebio Price Performance
Shares of LON:4BB opened at GBX 1,091 ($13.86) on Tuesday. The company’s fifty day moving average price is GBX 1,177.26 and its 200-day moving average price is GBX 1,279.03. The firm has a market capitalization of £139.76 million, a price-to-earnings ratio of -1,398.72 and a beta of 1.09. 4basebio PLC has a one year low of GBX 821 ($10.43) and a one year high of GBX 1,820 ($23.13). The company has a debt-to-equity ratio of 201.47, a current ratio of 2.73 and a quick ratio of 3.52.
4basebio Company Profile
Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients.
See Also
- Five stocks we like better than 4basebio
- What Does a Stock Split Mean?
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- What is a Stock Market Index and How Do You Use Them?
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for 4basebio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 4basebio and related companies with MarketBeat.com's FREE daily email newsletter.
